Form D — Reprieve Cardiovascular, Inc.
0001437749-25-019534 · filed 2025-06-05
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $35,852,110
- Total sold
- $30,852,111
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Reprieve Cardiovascular, Inc.
- CIK
- 1820102
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 459 Fortune Boulevard
Milford, MA 01757 - Phone
- 650-388-3676
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Hanson S. Gifford III · DirectorMilford, MA Find on LinkedIn ↗
-
James Eadie · DirectorMilford, MA Find on LinkedIn ↗
-
Ethan Benovitz · DirectorMilford, MA Find on LinkedIn ↗
-
Jan Garfinkle · DirectorMilford, MA Find on LinkedIn ↗
-
Tony Fields · Executive OfficerMilford, MA Find on LinkedIn ↗
-
Adam Bartnik · Executive OfficerMilford, MA Find on LinkedIn ↗
-
Mark Pacyna · Executive OfficerMilford, MA Find on LinkedIn ↗
-
David Neustaedter · DirectorMilford, MA Find on LinkedIn ↗
View original on SEC EDGAR.